0001104659-21-080362.txt : 20210611
0001104659-21-080362.hdr.sgml : 20210611
20210611200015
ACCESSION NUMBER: 0001104659-21-080362
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210610
FILED AS OF DATE: 20210611
DATE AS OF CHANGE: 20210611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSENWALD LINDSAY A MD
CENTRAL INDEX KEY: 0000941841
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38128
FILM NUMBER: 211012892
MAIL ADDRESS:
STREET 1: 375 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10152
FORMER NAME:
FORMER CONFORMED NAME: ROSENWALD LINDSAY MD
DATE OF NAME CHANGE: 19950316
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc.
CENTRAL INDEX KEY: 0001651407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472568632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 212-554-4366
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
tm2119513-3_4.xml
FORM 4
X0306
4
2021-06-10
0
0001651407
Checkpoint Therapeutics, Inc.
CKPT
0000941841
ROSENWALD LINDSAY A MD
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
1
0
0
0
COMMON STOCK
2021-06-10
4
A
0
16502
0.00
A
278782
D
The 16,502 shares of restricted Common Stock will vest on June 10, 2024, subject to Dr. Rosenwald's continued service on the board on such date.
Includes restricted shares of Common Stock which vest over various time periods, subject to Dr. Rosenwald's continued service on the board.
/s/ James F. Oliviero, Attorney-in-Fact
2021-06-11